Clinical Core
临床核心
基本信息
- 批准号:10431026
- 负责人:
- 金额:$ 13.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-16 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AIDS clinical trial groupAccountabilityAddressAdherenceAwardBaltimoreBeliefBioethicsBiological Specimen BanksBrazilCaringCenters for Disease Control and Prevention (U.S.)CitiesClinicClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical ServicesClinical TrialsCollaborationsCommunicationCommunitiesCountryCoupledDatabasesDetectionDevelopmentDiagnosticDiseaseEnsureEnvironmentFAIR principlesFacultyFeedbackFosteringFoundationsFundingGenerationsGoalsGrantHIVHealthHuman ResourcesHuman Subject ResearchIncidenceIncubatedIndiaInfectionInfrastructureInstitutionInstitutional Review BoardsInterdisciplinary StudyInternationalInternational Maternal Pediatric Adolescent AIDS Clinical TrialsInvestigationK-Series Research Career ProgramsKnowledgeLinkLogisticsMeasuresMentorsMentorshipMethodologyModelingMorbidity - disease rateNatural HistoryNewsletterPathogenesisPatientsPoliciesPopulationPreventionPreventive therapyProcessPublic HealthRecoveryReportingResearchResearch ActivityResearch InfrastructureResearch MethodologyResearch PersonnelResearch PriorityResearch SupportResourcesSeriesSouth AfricaSpecimenStreamStructureSumTalentsTherapeuticTraining SupportTranslatingTranslational ResearchTuberculosisUgandaUnited States National Institutes of HealthUniversitiesUpdateWorkWritingbasecareercase findingclinical careclinical implementationclinical research siteco-infectioncohortcomorbiditycostdata resourceepidemiology studyglobal healthimplementation interventionimprovedinnovationinterdisciplinary collaborationmaterial transfer agreementmeetingsmortalitymultidisciplinarynext generationnovelpatient populationpublic health researchsearchable databaseskillssupportive environmentsymposiumsynergismtransmission processweb site
项目摘要
ABSTRACT – JHU TRAC CLINICAL CORE (CC)
Tuberculosis (TB) remains a major global health problem and transformative clinical and translational science
research is needed to meaningfully bend the curve of TB incidence, transmission, morbidity and mortality. The
Johns Hopkins University (JHU) Center for Tuberculosis Research (CTR) is a global leader in innovation and
investigation, with ongoing research that spans the spectrum of clinical sciences and aligns strongly with the NIH
Strategic Research Priorities for TB research. However, to make further progress towards the WHO END TB
goals, it is critical to foster new interdisciplinary research and promote a new generation of TB researchers and
leaders. Therefore, the overarching goal of the JHU TRAC Clinical Core (CC) is to foster transformational
TB clinical research by providing access to populations, mentoring, and material support for the conduct
of clinical and translational science studies. The CC will add value and augment essential research
infrastructure to develop hypotheses, promote collaboration, and make resources accessible to foster and
develop the next generation of TB researchers. The foundation of the CC is our extensive patient populations
and biospecimen repositories domestically and internationally, coupled with a depth of technical, regulatory, and
clinical research expertise. The CC will strengthen clinical TB research capacity by bridging scientific resources
at JHU that are currently separated by departmental, physical, and logistical barriers. To this end, we propose to
first create novel avenues for exchange of research methods and ideas among new and established investigators
(Aim 1). We will participate in the structured weekly TRAC Seminar Series, with a focus on research in TB
detection, prevention, treatment, and cross-cutting topics, as well as the TRAC K-Club and K2R Club, and annual
TB Scientific Meeting and TRAC Data Fair. We will deliver improved opportunities for New and Early Stage
Investigators (NI/ESI) to present and receive feedback, while strengthening collective understanding of novel
developments in TB clinical science and fostering cross-disciplinary mentorship and collaborations. Given the
wide-reaching research activities in the JHU TRAC, NI and ESI will benefit from coordinated access and
knowledge of research opportunities, access to international and US clinics, patient cohorts and consortia, and
specimen repositories (Aim 2). A CC-supported Research Liaison will manage a consolidated searchable
database of JHU TRAC resources and research, and provide direct assistance and methodological guidance to
NI/ESI and trainees for linking to mentors, research opportunities, and data resources. We will ensure that NI/ESI
have the resources to successfully launch and execute clinical research (Aim 3) with provisions for a shared CC
Study Coordinator. Trainees will be supported in management of regulatory processes and study implementation.
JHU has excellent TB clinical research expertise. The TRAC CC will provide added value by ensuring needed
coordination and cross-institution communication and dissemination to create a vibrant TB clinical research
environment that is truly greater than the sum of its parts and ensure a pipeline of talented NI/ESI in TB research.
摘要- JHU TRAC临床核心(CC)
结核病(TB)仍然是一个重大的全球健康问题和变革性的临床和转化科学
需要进行研究,以使结核病发病率、传播率、发病率和死亡率的曲线发生有意义的弯曲。的
约翰霍普金斯大学(JHU)结核病研究中心(CTR)是创新和
调查,与正在进行的研究,跨越临床科学的频谱,并与NIH强烈一致
结核病研究的战略研究重点。然而,为了在世界卫生组织终结结核病方面取得进一步进展
为了实现这些目标,必须促进新的跨学科研究,培养新一代结核病研究人员,
领导人的人选信号因此,JHU TRAC临床核心(CC)的总体目标是促进转型
结核病临床研究通过提供接触人群、指导和物质支持的方式进行
临床和转化科学研究。CC将增加价值并增强基本研究
基础设施,以发展假设,促进合作,并使资源可用于促进和
培养下一代结核病研究人员。CC的基础是我们广泛的患者群体
和生物标本库,再加上深度的技术,监管,
临床研究专长。该委员会将通过整合科学资源来加强结核病临床研究能力
在JHU,目前被部门,物理和后勤障碍分开。为此,我们建议
首先为新老研究者之间的研究方法和思想交流创造新的途径
(Aim 1)。我们将参加结构化的每周TRAC研讨会系列,重点是结核病研究
检测、预防、治疗和跨领域专题,以及TRAC知识俱乐部和知识对知识俱乐部,
结核病科学会议和TRAC数据博览会。我们将为新的和早期阶段提供更好的机会
研究者(NI/ESI)提出并接受反馈,同时加强对新的
结核病临床科学的发展和促进跨学科的指导和合作。鉴于
JHU TRAC、NI和ESI的广泛研究活动将受益于协调的访问,
研究机会的知识,进入国际和美国诊所,患者队列和财团,以及
标本存放处(目标2)。CC支持的研究联络员将管理一个统一的可搜索的
JHU TRAC资源和研究数据库,并提供直接援助和方法指导,
NI/ESI和学员链接到导师,研究机会和数据资源。我们将确保NI/ESI
拥有资源,成功启动和执行临床研究(目标3),并提供共享CC
研究协调员。培训生将在监管流程管理和研究实施方面得到支持。
JHU拥有卓越的结核病临床研究专长。核心预算资源调拨目标协调委员会将通过确保所需的
协调和跨机构的沟通和传播,以创建一个充满活力的结核病临床研究
这是一个真正大于其各部分之和的环境,并确保结核病研究领域有才华的NI/ESI的管道。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAUNANK SHAH其他文献
MAUNANK SHAH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAUNANK SHAH', 18)}}的其他基金
Video DOT and Economic Incentives to promote adherence to LTBI therapy
视频 DOT 和经济激励措施促进对 LTBI 治疗的依从性
- 批准号:
10447735 - 财政年份:2021
- 资助金额:
$ 13.07万 - 项目类别:
Video DOT and Economic Incentives to promote adherence to LTBI therapy
视频 DOT 和经济激励措施促进对 LTBI 治疗的依从性
- 批准号:
10274703 - 财政年份:2021
- 资助金额:
$ 13.07万 - 项目类别:
Evaluation of National Video Directly Observed Therapy Implementation
全国视频直视治疗实施情况评价
- 批准号:
9556923 - 财政年份:2015
- 资助金额:
$ 13.07万 - 项目类别:
Evaluation of National Video Directly Observed Therapy Implementation
全国视频直视治疗实施情况评价
- 批准号:
9756227 - 财政年份:2015
- 资助金额:
$ 13.07万 - 项目类别:
Implementation Science Approaches for Novel TB Diagnostics in HIV Prevalent Areas
在艾滋病毒流行地区实施新型结核病诊断的科学方法
- 批准号:
8071436 - 财政年份:2011
- 资助金额:
$ 13.07万 - 项目类别:
Implementation Science Approaches for Novel TB Diagnostics in HIV Prevalent Areas
在艾滋病毒流行地区实施新型结核病诊断的科学方法
- 批准号:
8213622 - 财政年份:2011
- 资助金额:
$ 13.07万 - 项目类别:
Implementation Science Approaches for Novel TB Diagnostics in HIV Prevalent Areas
在艾滋病毒流行地区实施新型结核病诊断的科学方法
- 批准号:
8610872 - 财政年份:2011
- 资助金额:
$ 13.07万 - 项目类别:
Implementation Science Approaches for Novel TB Diagnostics in HIV Prevalent Areas
在艾滋病毒流行地区实施新型结核病诊断的科学方法
- 批准号:
8415935 - 财政年份:2011
- 资助金额:
$ 13.07万 - 项目类别:
相似海外基金
Attribution of Machine-generated Code for Accountability
机器生成代码的责任归属
- 批准号:
DP240102164 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Discovery Projects
CRII: SaTC: Privacy vs. Accountability--Usable Deniability and Non-Repudiation for Encrypted Messaging Systems
CRII:SaTC:隐私与责任——加密消息系统的可用否认性和不可否认性
- 批准号:
2348181 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Standard Grant
Global Governing Gaps and Accountability Traps for Solar Energy and Storage
太阳能和存储的全球治理差距和问责陷阱
- 批准号:
DP230103043 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Discovery Projects
Collaborative Research: U.S. institutions after COVID-19: Trust, accountability, and public perceptions
合作研究:COVID-19 后的美国机构:信任、责任和公众看法
- 批准号:
2422394 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Standard Grant
The Tipuna Project: Intergenerational Healing, Settler Accountability and Decolonising Participatory Action Research in Aotearoa
Tipuna 项目:新西兰的代际疗愈、定居者责任和非殖民化参与行动研究
- 批准号:
AH/X008223/1 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Research Grant
Collaborative Research: The Architecture of Accountability in 21st Century Latin America
合作研究:21 世纪拉丁美洲的问责架构
- 批准号:
2314749 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Standard Grant
Conference: Understanding Democracy, Elections, and Political Accountability
会议:了解民主、选举和政治责任
- 批准号:
2321010 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Standard Grant
Ethical Industry 4.0: Embedding Legality, Integrity and Accountability in Digital Manufacturing Ecosystems
道德工业 4.0:将合法性、诚信和责任融入数字制造生态系统
- 批准号:
2412678 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Standard Grant
CAREER: Integrating Trust and Accountability into Compliance Enforcement for a Secure Internet of Things
职业:将信任和问责融入安全物联网的合规执行中
- 批准号:
2237012 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Continuing Grant
Collaborative Research: SaTC: CORE: Small: Accountability for Central Bank Digital Currency
协作研究:SaTC:核心:小型:中央银行数字货币的责任
- 批准号:
2325477 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Continuing Grant